Is Future medicinal chemistry SCI Indexed? Indexing Status & Metrics

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor

3.63

Citation rate 3.21 1,098 total citations

h5-index 32 h5 depth signal

Cited share 77.6% 264 of 340

Total citations 1,098 Citation footprint

Metric signal 3.80 External metric anchor

Self-citation 3.3% 36 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

China 390

India 305

United States 258

Egypt 171

Italy 151

Citing Fields of Research

Synthesis 480

Cancer Drugs 266

Protein Structure & Folding 219

Cancer, Autophagy & Apoptosis 218

Drug Delivery Systems 206

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 3,252 Articles tracked across the journal lifetime

Indexed publication set 340 264 cited publications

Last 12 months 223 18.6 publications/month

Open access share 2.2% 5 OA publications in the last year

Leading citing country China 390 citing publications

Leading citing field Synthesis 480 citing publications

Latest tracked publication 20 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE

v1n1, Apr. 2009-

PubMed

v1n1, Apr. 2009-

PMC

Active Coverage

Research Focus & Classification

Indexed Subjects

Synthesis Cancer Drugs Cancer, Autophagy & Apoptosis Diabetes Drug Delivery Systems Antibiotic & Antibacterial Agents

Broad Categories

Chemistry Pharmacy Synthesis Cancer Drugs Protein Structure & Folding Cancer, Autophagy & Apoptosis Molecular & Cellular Toxicology Parasitology Studies

MeSH Descriptors

Chemistry, Pharmaceutical

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

01 20 October 2026

DOI 10.1080/17568919.2026.2748648

Therapeutic prospects of thiazolo[3,2- b ][1,2,4]triazole derivatives: a comprehensive review of biological activities and structure–activity relationship insights

Open DOI

Priya Jajoriya, Sangeeta Sharma, Annu Jangra et al.

02 18 October 2026

DOI 10.1080/17568919.2026.2748644

Integrated machine learning, pharmacophore screening, and structure-based computational approaches for the identification of novel JAK3 inhibitors

Open DOI

Muhammad Yasir, Jinyoung Park, Eun-Taek Han et al.

03 16 October 2026

DOI 10.1080/17568919.2026.2748646

Multicomponent synthesis of 2-amino-tetrahydro-4 H -chromenes catalyzed by chitosan and evaluation of anti- Leishmania activity

Open DOI

Poliana G. Abrantes, Paloma G. Abrantes, Renata R. Magalhães et al.

04 16 October 2026

DOI 10.1080/17568919.2026.2748643

Synthesis, in silico study and cytotoxic evaluation of new benzimidazole derivatives as potential aromatase inhibitors

Open DOI

Ayşen Işık, Nour El-Huda Daoud, Kezban Uçar Çiftçi et al.

05 6 October 2026

DOI 10.1080/17568919.2026.2732260

Recent advances of GPR40 agonists as potential anti-Alzheimer’s agents

Open DOI

Jefferson Muniz Alves da Silva, Arthur Eugen Kümmerle, Daniel Alencar Rodrigues et al.

06 6 October 2026

DOI 10.1080/17568919.2026.2739927

Computational drug design, synthesis, acetylcholinesterase inhibition and kinetic evaluation of novel benzothiazole-thiadiazole/oxadiazole derivatives

Open DOI

Ramesh Ambatwar, Pooja Singh, Suman Ghosh et al.

1. In the era of innovative therapeutics, Alzheimer’s disease (AD) remains one of the most challenging neurodegenerative disorders to treat [1]. As per the World Alzheimer’s Report, the number of i...

07 4 October 2026

DOI 10.1080/17568919.2026.2726189